老年早期高危宫颈癌根治术后同步放化疗的临床疗效及对远期生存预后的影响
CSTR:
作者:
作者单位:

(1.上海市第一妇婴保健院 同济大学附属第一妇婴保健院急诊科,上海 201202;;2.复旦大学附属妇产科医院重症监护病房,上海 200082)

作者简介:

通讯作者:

中图分类号:

基金项目:

上海市科学技术委员会科研项目(20Y11907100)


Clinical efficacy of concurrent chemoradiotherapy after radical hysterectomy and its impact on long-term survival prognosis in elderly patients with early-stage high-risk cervical cancer
Author:
Affiliation:

(1.Department of Emergency, Shanghai First Maternity and Infant Hospital, First Maternity and Infant Hospital Affiliated to Tongji University, Shanghai 201202, China;2.Intensive Care Unit, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200082, China)

Fund Project:

This work was supported by Research Project of Shanghai Municipal Science and Technology Commission (20Y11907100).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨老年早期高危宫颈癌根治术后同步放化疗的临床疗效,并分析对远期生存预后的影响。方法 选取2019年1月至2022年2月在上海市第一妇婴保健院进行宫颈癌根治术治疗的130例老年早期高危宫颈癌患者为研究对象,根据治疗方法将其分为两组,每组患者65例。对照组术后行序贯放化疗,观察组术后行同步放化疗。采用放射免疫法分析患者血清性激素水平;应用酶联免疫吸附试验(ELISA)检测患者血清中胸苷激酶1(TKI)、人附睾蛋白4(HE4)、细胞角质蛋白19片段抗原21-1(CYFRA21-1)水平、肿瘤特异性生长因子(TSGF)、糖链抗原125(CA125)、血清鳞状细胞癌抗原(SCC);随访记录受试者1、2年生存情况。采用SPSS 23.0统计软件对文中数据进行分析,依据数据类型,采用t检验或χ2检验进行组间比较。结果 观察组治疗有效率高于对照组,差异有统计学意义(95.92%和86.15%;P<0.05);观察组治疗后卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E2)水平均低于对照组,差异有统计学意义[(13.55±2.17)和(18.64±2.59)μ/L,(11.27±2.61)和(15.64±2.67)μ/L,(82.36±9.11)pmol/L和(124.26±15.88)pmol/L;均P<0.05];观察组孕酮(P)水平较对照组更高,差异有统计学意义[(9.55±1.02)和(7.64±0.81)nmol/L;P<0.05];观察组治疗后TKI、HE4、CYFRA21-1水平均较对照组更低,差异均有统计学意义[(0.69±0.08)和(1.79±0.22)pmol/L,(54.22±6.17)和(95.44±10.23)pmol/L,(5.26±0.61)和(8.44±0.91)μg/L;均P<0.05];观察组治疗后TSGF、CA125、血清SCC水平均较对照组更低,差异均有统计学意义[(32.54±4.28)和(47.11±5.29)U/ml,(14.23±2.54)和(19.56±2.33)U/ml,(2.34±0.28)和(3.65±0.39)μg/L;均P<0.05];两组1、2年生存率比较差异无统计学意义(P>0.05)。结论 在老年早期高危宫颈癌根治术后,同步放化疗短期效果显著优于序贯放化疗,且前者对性激素水平影响更低,更能有效抑制肿瘤细胞的增殖和转移,但长期生存率尚有待进一步研究验证。

    Abstract:

    Objective To investigate the clinical efficacy of concurrent chemoradiotherapy (CCRT) after radical hysterectomy in elderly patients with early-stage high-risk cervical cancer and to analyze its impact on long-term survival prognosis. Methods A total of 130 elderly patients with early-stage high-risk cervical cancer who underwent radical hysterectomy at the First Maternity and Infant Hospital of Shanghai from January 2019 to February 2022 were enrolled as the research subjects. According to different treatment methods, they were divided into two groups (65 in each):the control group receiving sequential radiotherapy and chemotherapy (SCRT) and the observation group receiving CCRT after surgery. Radioimmunoassay was used to analyze the serum sex hormone levels. Enzyme-linked immunosorbent assay (ELISA) was used to measure thymidine kinase 1 (TKI), human epididymal protein 4 (HE4), cytokeratin 19 fragment antigen 21-1 (CYFRA21-1), tumor-specific growth factor (TSGF), carbohydrate antigen 125 (CA125), and serum squamous cell carcinoma (SCC) antigen. Survival at 1-year and 2-year follow-up was recorded. SPSS 23.0 was used for data analysis. According to the data type, t test orχ2 test was used for inter-group comparison. Results The treatment efficacy rate of the observation group was higher than that of the control group, and the difference was statistically significant (95.92% vs 86.15%; P<0.05). After treatment, the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2) in the observation group were all lower than those in the control group, and the difference was statistically significant [(13.55±2.17) vs (18.64±2.59)μ/L, (11.27±2.61) vs (15.64±2.67)μ/L, (2.36±9.11) vs (124.26±15.88) pmol/L; all P<0.05]. The progesterone levels in the observation group was higher than that in the control group [(9.55±1.02) vs (7.64±0.81) nmol/L; P<0.05]. Post-treatment levels of TKI, HE4, and CYFRA21-1 in the observation group were all lower than those in the control group [(0.69±0.08) vs (1.79±0.22) pmol/L, (54.22±6.17) vs (95.44±10.23) pmol/L, (5.26±0.61) vs (8.44±0.91) μg/L; all P<0.05]. The levels of TSGF, CA125, and serum SCC in the observation group were all lower than those in the control group[(32.54±4.28) vs (47.11±5.29) U/ml, (14.23±2.54) vs (19.56±2.33) U/ml, (2.34±0.28) vs (3.65±0.39)μg/L; all P<0.05]. There were no significant differences in the 1-year and 2-year survival rates between two groups (P>0.05). Conclusion Concurrent chemoradiotherapy has significantly better short-term efficacy than sequential chemoradiotherapy after radical hysterectomy in elderly patients with early-stage high-risk cervical cancer and has less impact on sex hormone levels and more effective suppression of tumor cell proliferation and metastasis. However, long-term survival benefits warrant further investigation and verification.

    参考文献
    相似文献
    引证文献
引用本文

陈斐凤,沈维贞,张月.老年早期高危宫颈癌根治术后同步放化疗的临床疗效及对远期生存预后的影响[J].中华老年多器官疾病杂志,2025,24(7):508-512
DOI:10.11915/j. issn.1671-5403.2025.07.111

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-07-16
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-23
  • 出版日期:
文章二维码